| Insulin name (Brand) | Onset (hours) | Peak (hours) | Duration (hours) |
| Rapid acting | |||
| Lispro (Humalog) | ~0.25 | 0.5 - 2.5 | ≤5 |
| Aspart (Novolog) | ~0.25 | 1 - 3 | 3 - 5 |
| Glulisine (Apidra) | ~0.25 | 1.6 - 2.8 | 3 - 4 |
| Human insulin inhalation powder (Afrezza) | ~0.25 | ~1 | 2.5 - 3 |
| Short acting | |||
| Regular (Novolin R or Humulin R) | 0.5 - 1 | 2.5 - 5 | 4 - 12 |
| Intermediate acting | |||
| NPH (Novolin N or Humulin N) | 1 - 2 | 4 - 12 | 14 - 24 |
| Long acting | |||
| Glargine(Lantus)100 units/mL | 3 - 4 | None | >24 |
| Glargine(Toujeo) 300 units/mL | 6 | None | 24 - 36 |
| Detemir (Levemir) | 3 - 4 | 3 - 9 | Dose dependent 6 - 23 |
| Degludec(Tresiba)100 units/ml; 200 units/ml | 3 - 4 | None | >42 |
| Combination products | |||
| 70/30 NPH/regular (Humulin or Novolin) | 0.5 - 1 | 2 - 12 | 18 - 24 |
| 70/30 NPH/aspart (Novolog Mix) | ~0.25 | ~1 - 4 | 18-24 |
| 75/25 NPH/lispro or 50/50 NPH/lispro (Humalog Mix) | ~0.25 | ~1 - 5 | 14 - 24 |
| 70/30Degludec/aspart (Ryzodeg) | ~0.25 | ~1 - 4 | >42 |
| Concentrated insulin | |||
| U-500 regular (Humulin R U-500) | 0.5 - 1 | 2.5 - 5 | Up to 24 |